AI Article Synopsis

  • Endoscopic mucosal resection (EMR) is a common but challenging procedure for treating early gastric cancer (EGC), especially concerning the identification of cancer-free resection margins, particularly with piecemeal techniques.
  • A study involving 149 EGC patients examined the risks, local recurrence rates, and mortality associated with piecemeal EMR compared to en bloc EMR, tracking outcomes over 10 years with annual follow-ups.
  • Results indicated that although there were significant differences in unclear margins between the two methods, EMR was conducted without complications, and a larger lesion size (over 20 mm) increased the risk for necessitating piecemeal EMR.

Article Abstract

Background: Endoscopic mucosal resection (EMR) is a therapy for early gastric cancer (EGC) that can be provided relatively easily and safely in any institution. Identification of the resection margin is a problem in EMR, especially in cases of piecemeal EMR. Despite the long-standing widespread use of piecemeal EMR for EGC, its limitation and long-term outcomes in clinical practice have not been fully evaluated. This study aimed to determine the risk factors of piecemeal EMR, the local recurrence rates, and the mortality rate.

Methods: A cross-sectional, retrospective cohort study was performed to investigate the risks of piecemeal EMR for patients with the diagnosis of differentiated adenocarcinoma localized to the mucosa. Local recurrence of EGC was investigated by annual follow-up esophagogastroduodenoscopy (EGD) for 10 years. EMR was performed with snare electrocautery using a two-channel scope. When a resection margin was clearly positive for cancer, additional surgery was performed soon after the initial EMR.

Results: For the 149 EGC patients (mean age, 68.8 ± 9.8; male, 77%) who underwent EMR between 1995 and 2001, EMR was performed en bloc in 66 cases and piecemeal in 83 cases. The comorbid conditions existing in 34 of the 149 patients included other malignancies (n = 12), heart failure (n = 5), pulmonary disease (n = 7), liver cirrhosis (n = 4), and other illness (n = 6). However, EMR was completed without complication. The mean area (length × width) of the lesions was 404 ± 289 mm(2) in the piecemeal group and 250 ± 138 mm(2) in the en bloc groups. The en bloc and piecemeal EMR groups differed significantly in terms of unclear horizontal margins but not in terms of unclear vertical margins. Multiple logistic regression suggested that the adjusted odds ratio for maximum diameters exceeding 20 mm for piecemeal EMR was 2.71 (95% confidence interval [CI], 1.30-5.64). According to Kaplan-Meier estimates, the local recurrence rate was 30% (95% CI, 20-40%) at both 5 and 10 years. No recurrence was observed in the en bloc group. The adjusted hazard ratio of unclear horizontal margins for local recurrence was 1.63 (95% CI, 1.12-2.36). A total of 24 patients died after EMR because of comorbid conditions, including other malignancies (n = 11), cardiovascular disease (n = 6), pulmonary disease (n = 4), liver cirrhosis (n = 2), and traffic accident (n = 1). However, no patient died of gastric cancer during the 10-year follow-up period.

Conclusions: An evaluation of horizontal margins in terms of local recurrence after piecemeal EMR is important, and en bloc resection is recommended. Close follow-up assessment is warranted, especially within 5 years in cases of unclear margin resection after piecemeal EMR. The use of EMR is safe even for patients with severe comorbid conditions.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00464-011-1830-yDOI Listing

Publication Analysis

Top Keywords

piecemeal emr
32
local recurrence
24
emr
16
gastric cancer
12
comorbid conditions
12
horizontal margins
12
piecemeal
11
early gastric
8
endoscopic mucosal
8
mucosal resection
8

Similar Publications

Background And Aims: Endoscopic mucosal resection (EMR) of large colorectal lesions can be challenging, and residual lesions after EMR can progress to colorectal cancer. We aimed to assess the efficacy and safety of adding thermal ablation of margins [using argon plasma coagulation (APC) or snare tip soft coagulation (STSC)] in reducing recurrence rates after EMR.

Methods: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) identified from PubMed, Cochrane Library, and Embase.

View Article and Find Full Text PDF

Background:  Piecemeal endoscopic mucosal resection (EMR) of large (≥ 20 mm) nonpedunculated colorectal polyps (LNPCPs) is succeeded by a 6-month surveillance endoscopy to evaluate the post-EMR scar for recurrence. Data from expert centers suggest that routine tattoo placement and scar biopsies can be omitted, but data from community hospitals are lacking.

Methods:  The agreement between optical assessment and histological confirmation by routine biopsies was evaluated in a post-hoc analysis of the STAR-LNPCP study (NTR7477), containing prospective data on 6-month post-EMR scar assessments in 30 Dutch community hospitals (October 2019 to May 2022).

View Article and Find Full Text PDF

Esophageal ESD Training; Perspective of West vs. East.

Curr Gastroenterol Rep

December 2025

Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

Article Synopsis
View Article and Find Full Text PDF

Endoluminal approaches for colorectal neoplasia in inflammatory bowel disease: a viable alternative for colectomy?

J Gastrointest Surg

February 2025

Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address:

Background: Endoscopic resection of visible dysplastic lesions in patients with inflammatory bowel disease (IBD) is an alternative to colectomy. The endoscopic techniques that can be used include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and ESD combined with EMR. These endoscopic approaches may allow organ preservation in patients with IBD.

View Article and Find Full Text PDF

Endoscopic Resection for Superficial Non-Ampullary Duodenal Epithelial Tumors.

Gut Liver

January 2025

Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.

Article Synopsis
  • - The rise in superficial non-ampullary duodenal epithelial tumors (SNADETs) is linked to advancements in endoscopic imaging techniques and greater awareness of the condition.
  • - Endoscopic resection is the primary treatment for SNADETs, utilizing various methods like cold snare polypectomy and underwater EMR, but poses more risks due to unique anatomical challenges in the duodenum.
  • - Treatment strategies depend on the tumor size: smaller lesions may be treated with less invasive techniques, while larger or suspected cancerous tumors necessitate more aggressive approaches like endoscopic submucosal dissection or surgical resection.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!